MediRama

Contact us LinkedIn

Resources

[MediRama EDGE] When Companion Diagnostics Change: Assays, Cutoffs, Samples and Regulatory Inputs in Oncology Drug Development.

  • Writer:관리자
  • Date:2026-03-03

When Companion Diagnostics Change: Assays, Cutoffs, Samples and Regulatory Inputs in Oncology Drug Development.

송출일 : 2026.02.26 

 

https://www.youtube.com/watch?v=5ZMexgAGs4A


PREV
[MediRama EDGE] A Review of Clinical Pharmacology Considerations in Antibody–Drug Conjugates Approved by the US Food and Drug Administration Between 2000 and 2025.
There's no next post.
NEXT
LIST